Animal Health and Innovation Act of 2018
This bill amends the Federal Food, Drug, and Cosmetic Act to expand the authority of the Food and Drug Administration to conditionally approve a new animal drug that (1)is intended to treat a serious or life-threatening disease or condition or address an unmet animal or human health need, and (2)a demonstration of effectiveness would require a complex or particularly difficult study or studies.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.